Ovoca Bio plc
OVB.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | £0 | £0 | £0 | £0 |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | – | – | – | – |
| R&D Expenses | £0 | £419 | £2,456 | £3,551 |
| G&A Expenses | £658 | £1,866 | £2,053 | £6,040 |
| SG&A Expenses | £658 | £1,866 | £2,053 | £6,096 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £56 |
| Other Operating Expenses | -£655 | £2,814 | £1,456 | £236 |
| Operating Expenses | £3 | £5,099 | £5,423 | £5,860 |
| Operating Income | -£3 | -£5,099 | -£5,577 | -£5,330 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | £0 | -£5 | -£35 | £83 |
| Pre-Tax Income | -£3 | -£5,104 | -£5,612 | -£5,247 |
| Tax Expense | £0 | £0 | £0 | £0 |
| Net Income | -£746 | -£4,702 | -£5,612 | -£5,475 |
| % Margin | – | – | – | – |
| EPS | 0 | -0.068 | -0.069 | -0.067 |
| % Growth | 100% | 1.2% | -2.5% | – |
| EPS Diluted | 0 | -0.063 | -0.069 | -0.067 |
| Weighted Avg Shares Out | 20,722,222 | 75,113 | 81,564 | 81,564 |
| Weighted Avg Shares Out Dil | 81,564 | 81,564 | 81,564 | 81,564 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £4 | £0 |
| Interest Expense | £0 | £0 | £39 | £21 |
| Depreciation & Amortization | £300 | £300 | £531 | £84 |
| EBITDA | £51 | -£549 | -£3,436 | -£5,776 |
| % Margin | – | – | – | – |